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RLIP76 (RalBP1) is a multidomain protein that inter-
acts with multiple small G protein families: Ral via
a specific binding domain, and Rho and R-Ras via a
GTPase activating domain. RLIP76 interacts with
endocytosis proteins and has also been shown to
behave as a membrane ATPase that transports
chemotherapeutic agents from the cell. We have
determined the structure of the Ral-binding domain
of RLIP76 and show that it comprises a coiled-coil
motif. The structure of the RLIP76-RalB complex
reveals a novel mode of binding compared to the
structures of RalA complexed with the exocyst
components Sec5 and Exo84. RLIP76 interacts with
both nucleotide-sensitive regions of RalB, and key
residues in the interface have been identified using
affinity measurements of RalB mutants. Sec5,
Exo84, and RLIP76 bind Ral proteins competitively
and with similar affinities in vitro.
INTRODUCTION
Cell migration is a normal, essential process, but in cancer
progression it is the basis for the ability of tumor cells tometasta-
size to new areas of the body, a process that leads to 90% of
cancer deaths (Sporn, 1996). Approximately 50% of metastatic
tumors contain mutations in the small G protein Ras, and one of
the three main effector pathways downstream of Ras is
controlled by RalGEFs, which are exchange factors (and there-
fore activators) for another pair of small G proteins, RalA and
RalB. Cells transformed with either an activated Ras variant
(12V, 37G) that only interacts with the RalGEFs or with constitu-
tively active RalGEFproduced aggressive, infiltrativemetastases
when injected intomice. Thesewere inhibited by dominant nega-
tive RalB (Ward et al., 2001), demonstrating that the RalGEF
pathway alone is sufficient to induce a metastatic phenotype.
In bladder cancer lines, EGF stimulation activates Ral, and
elevated levels of activated Ral are confined to metastatic cells
(Gildea et al., 2002). It is therefore clear that the Ral pathway
represents a potential target for the treatment of human meta-
static cancers.Structure 18, 98The Ral signaling pathway(s) responsible for conferring meta-
static potential on cancer cells is less well defined. The effectors
for the Ral GTPases regulate a wide variety of cellular functions
and include phospholipase D (Jiang et al., 1995), the actin
filament cross-linking protein filamin A (Ohta et al., 1999), the
Y-box transcription factor ZONAB (ZO-1 associated nucleic
acid binding protein) (Frankel et al., 2005), phospholipase C d1
(Sidhu et al., 2005), two components of the exocyst complex,
Sec5 and Exo84, (Moskalenko et al., 2002, 2003; Sugihara
et al., 2002) and RLIP76 (RalBP1/RIP1) (Jullien-Flores et al.,
1995; Cantor et al., 1995; Park and Weinberg, 1995). RLIP76
is a multifunctional protein, containing a variety of domains
and motifs (Figure 1A). Its RhoGAP domain acts on Rac1 and
Cdc42, linking Ral with Rho family signaling (Jullien-Flores
et al., 1995; Cantor et al., 1995; Park and Weinberg, 1995) and
therefore control of the actin cytoskeleton and cell motility.
RLIP76 is also involved in endocytosis and tyrosine kinase
receptor signaling via its ability to bind to AP2 and POB1 through
its N-terminal and C-terminal regions, respectively (Yamaguchi
et al., 1997; Jullien-Flores et al., 2000).
Although RLIP76 is thought to be primarily cytosolic, it trans-
locates to the membrane upon binding by Ral. RLIP76 contains
two ATP-binding sites (Awasthi et al., 2001) that allow it to func-
tion as an ATP-dependent transporter protein and efflux pump
for small molecules, including anticancer drugs and endogenous
metabolites (Awasthi et al., 2002).
We have solved the structure of the minimal Ral GTPase-
binding domain (GBD) of RLIP76 by NMR, both alone and in
complex with RalB. This represents the first structural data avail-
able for RLIP76 and also reveals, for the first time, the conforma-
tion of RalB in complex with one of its effectors. The RLIP76GBD
is a coiled-coil, which although identified as a binding motif for
other small G protein families (Modha et al., 2008; Panic et al.,
2003), is unique for an effector of the Ras family of small
G proteins. Comparison of the free and bound structures of
RalB and RLIP76 GBD shows that there are small changes in
the orientation of the RLIPGBD a helices and in the loop between
them. The regions of RalB that are involved in the interaction
with RLIP76 GBD include both the switch regions that change
conformation on nucleotide exchange; however, 31P NMR
experiments reveal that there is still residual dynamics in
switch 1 after complex formation. We have used the structure
to design mutants to investigate the thermodynamics of the
binding interface between RalB and RLIP76. This combination5–995, August 11, 2010 ª2010 Elsevier Ltd All rights reserved 985
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Figure 1. Structures of RLIP76 GBD Alone
and in Complex with RalB
(A) Domain structure of RLIP76. The approximate
positions of the RhoGAP domain, the Ral-binding
domain (GBD), and coiled-coil region are repre-
sented as colored boxes. The regions found to
interact with AP2 and POB1 are indicated, and
the locations of the putative ATP-binding sites
are marked with red arrows (Awasthi et al., 2001).
(B) Structure of free RLIP76 GBD. On the left is the
backbone trace of the family of structures consis-
tent with the NMR restraints, on the right is the
closest structure to the mean. All structure figures
were produced using Molscript (Kraulis, 1991) and
rendered with Raster3D (Merritt and Bacon, 1997).
(C) Structure of the RLIP76 GBD-RalB complex.
Ral is shown in blue and RLIP76 is lilac. On the
left is the backbone trace of the lowest energy
structures, on the right is the closest structure to
the mean.
Structure
Solution Structure of the RalB-RLIP76 Complexof structural and thermodynamic information could be used to
assist rational drug design of therapeutics directed toward dis-
rupting the RalB-RLIP76 complex.
RESULTS AND DISCUSSION
Structure of the RLIP76 GBD
The quality of the NMR data of wild-type RLIP76 GBD protein,
comprising residues 393–446, suggested that the domain was
partially dimerized in solution, and this notion was confirmed
by analytical gel filtration experiments. Electrospray ionization
mass spectrometric analysis in the presence and absence
of the reducing agent tris(2-carboxyethyl)phosphine (TCEP)
revealed that dimerization was the result of disulphide bond
formation (data not shown). The single Cys, residue 411, in the
RLIP76 GBD was mutated to Ser, and the resulting protein was
judged to be fully monomeric in solution by analytical gel filtra-
tion, mass spectrometry, and analytical ultracentrifugation.
Analytical gel filtration analyses were also used to confirm that
the mutation of Cys-411 to Ala did not affect the ability of the
RLIP GBD to complex with RalB (data not shown).
The RLIP76 GBD backbone resonances were assigned as
described elsewhere (Fenwick et al., 2008b). Distance restraints
were generated from a 3D 15N-separated NOESY and from
a 2D 1H NOESY recorded on unlabeled RLIP76. A total of 998986 Structure 18, 985–995, August 11, 2010 ª2010 Elsevier Ltd All rights reserveddistance restraints were used in the first
round of structure calculation, of which
575 were unambiguous and 423 were
ambiguous. After eight rounds of structure
calculation, where at each round the
ambiguity of the restraints was reduced,
there were 737 unambiguous and 560
ambiguous restraints. Thirty-nine hy-
drogen bond restraints were included for
residues whose backbone amides were
undergoing negligible exchange with the
solvent in a CLEANEX series of experi-
ments (Hwang et al., 1998) and whoseNOE patterns indicated that they were within an a-helix. The final
family of 50 structures (Figure 1B) shows that the RLIP76 GBD
forms an antiparallel coiled-coil comprising two a helices
(a1RLIP76 and a2RLIP76) that are each20 amino acid residues in
length (395–415 and 423–442). The coiled-coil is held together
by hydrophobic interactions between aliphatic residues: Leu,
Ile, and a single Val sidechain comprise the core of the coil.
A coiled-coil motif is used by several effector proteins for
bindingmembers of various families of the small G protein super-
family, such as the Rho family (i.e., HR1 domains that bind to
RhoA and Rac1) (Maesaki et al., 1999; Modha et al., 2008), the
Arf family (i.e., the GRIP domains that bind to Arl1) (Panic et al.,
2003; Wu et al., 2004), and the Rab family (i.e., Rab-binding
proteins such as Rabenosyn-5) (Eathiraj et al., 2005). The
RLIP76 GBD structure, however, represents the first structural
information obtained for a coiled-coil motif that binds to a Ral
protein and indeed to any member of the Ras family. Although
it is perhaps not surprising, however, given that coiled-coil
domains have been found to bind to all of the other small G
protein families, with the exception of Ran, that a coiled-coil
would also be found in a Ras family effector.
Structure of the RLIP76 GBD-RalB Complex
The backbone resonances of the RLIP76 GBD and RalB in the
complex were assigned as described elsewhere (Fenwick
Table 1. Structural Statistics for RLIP76 GBD and RalB$GMPPNP–RLIP76 GBD
Experimental restraints used in structure calculation
RLIP76 RalB$GMPPNP–RLIP76
Unambiguous NOEs 737 4470
Ambiguous NOEs 560 1393
Dihedral angle restraints (f + c) — 292
Hydrogen bonds (RLIP76) 39 39
Structural statistics
RLIP76 RalB$GMPPNP–RLIP76
Coordinate precision (A˚)
<SA>a <SA>c
b <SA>a <SA>c
b
RMSD of backbone atoms (12–180, 394–444) 0.54 ± 0.15 A˚ 0.35 A˚ 0.79 ± 0.11 A˚ 0.59 A˚
RMSD of heavy atoms (12–180, 393–444) 1.11 ± 0.13 A˚ 0.87 A˚ 1.03 ± 0.12 A˚ 0.85 A˚
RMS deviations
From experimental restraints:
NOE distances (A˚) 2.00 3 102 ± 1.4 3 103 1.94 3 102 1.57 3 102 ± 8.0 3 104 1.51 3 102
Dihedral angles (o) — 0.58 ± 9.2 3 102 0.40
From idealized geometry:
Bonds (A˚) 3.89 3 103 ± 1.2 3 104 3.95 3 103 3.58 3 103 ± 6.4 3 105 3.57 3 103
Angles (o) 0.51 ± 1.2 3 102 0.48 0.50 ± 1.2 3 102 0.49
Impropers (o) 1.21 ± 0.1 1.22 1.32 ± 7.5 3 102 1.37
Ramachandran analysisc
Most favored regions 92.2% 94.1% 84.6% 85.0%
Allowed regions 7.5% 5.9% 13.1% 13.1%
Generously allowed regions 0.1% 0.0% 1.0% 0.9%
Disallowed regions 0.3% 0.0% 1.3% 0.9%
a<SA> represents the average RMS deviations for the ensemble.
b <SA>c represents values for the structure that is closest to the mean.
c PROCHECK (Laskowski et al., 1993).
Structure
Solution Structure of the RalB-RLIP76 Complexet al., 2008a, 2008b). All RLIP76 backbone atoms were assigned
in the complex, with the exception of the three residues at the
extreme N terminus (393–395), and the side-chain assignments
were essentially complete. RalB backbone atoms were fully
assigned, with the exception of Glu-44 and Thr-46 in switch 1;
the resonances for these atoms were also missing or weak in
the spectra of free RalB$GMPPNP (Prasannan et al., 2007). All
side-chains were assigned in RalB, although Lys-27, Glu-44,
Asp-49, Ser-50, and Tyr-51 were not complete. Hydrogen bond
restraints were included for RLIP76, as above, and pairs of
dihedral angle restraints, whichwere calculated using the TALOS
program (Cornilescu et al., 1999) according to the experimentally
determined backbone chemical shifts for both proteins (Table 1).
Distance restraints were obtained from 15N-separated and
13C-separated NOESY experiments, recorded on appropriately
labeled samples. These were translated using ARIA into 3547
unique unambiguous restraints and 2200 ambiguous restraints.
Of these, there were 45 unambiguously assigned distance
restraints between the two components of the complex. After
eight rounds of structure calculation, wherein the ambiguity of
the restraintswas reduced at each round, therewere 4461 unam-
biguous restraints and 1408 ambiguous distance restraints.
The RLIP76 GBD binds to one face of RalB in such a way that
it contacts the two main regions that change conformation
when the G protein is activated by GDP exchanging for GTPStructure 18, 98(Figure 1C). These regions, known as switch 1 (Glu-41RalB to
Tyr-51RalB) and switch 2 (Thr-69RalB to Asn-81RalB), are generally
involved in interactions with G protein effectors, because their
molecular topography is sensitive to the nucleotide status of
the G protein.
The N-terminal region of switch 1 (Glu-41RalB to Lys-47RalB)
forms a flexible loop that includes the conserved residue
Thr-46 (equivalent to Thr-35 in Ras). Thr-46 forms a hydrogen
bond with the g-phosphate of GTP, contributing to the con-
formational change that ensues when the nucleotide is
exchanged. The C-terminal amino acids of switch 1, residues
48–52RalB, make significant interactions with RLIP76, whereas
theN terminus of switch 1, including Thr-46RalB, does not interact
with RLIP76 at all. Ser-50RalB to Arg-52RalB comprises the begin-
ning of the second b strand in RalB (b2RalB) and contacts
residues in a2RLIP76 (Figures 2A and 2C). In particular, intermo-
lecular NOEs were observed between the amide of Ser-50RalB
and the side-chains of Thr-437RLIP76 and Gln-433RLIP76 and
also between the side-chains of Thr-437RLIP76 and Tyr-51RalB.
Leu-67RalB, which is in the region between the switches, also
contacts a2RLIP76 (Figure 2A), predominantly via interactions
with Trp-430RLIP76 (Figure 2E).
Interactions between RLIP76 and switch 2 of RalB are more
extensive than those of switch 1 and involve most of switch 2
interacting with both a helices of RLIP76. The N terminus of5–995, August 11, 2010 ª2010 Elsevier Ltd All rights reserved 987
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Figure 2. Details of the Interactions between RalB and the RLIP76 GBD
(A) Interactions involving the RalB switch 1 and interswitch regions. RalB is shown in blue and the RLIP76 GBD is in lilac. The side-chains are shown in a ball-and-
stick representation with sticks in the same colors as the ribbon for eachmolecule and the atoms colored as follows: carbon, dark gray; oxygen, red; and nitrogen,
blue.
(B) Interactions involving the RalB switch 2. The color scheme is the same as in (A).
(C) Summary of all interactions between the proteins. Putative hydrogen bonds and salt bridges are shown as dotted lines between the participating atoms. RalB
is shown in blue and RLIP76 is shown in lilac.
(D) Interactions involving His-413RLIP76. Side-chains are shown in a space-filling representation superimposedwith a ball-and-stick. The color scheme is the same
as in (A).
(E) Trp-430 of RLIP76 is surrounded by a cage of RalB side-chains. The color scheme is the same as in (A).
Structure
Solution Structure of the RalB-RLIP76 Complexswitch 2, comprising residues Asp-74RalB, Tyr-75RalB, Ala-76RalB,
Ala-77RalB, and Ile-78RalB, interacts with a1RLIP76 (Figures 2B
and 2C), and multiple intermolecular contacts were observed
between these residues and His-413RLIP76, Leu-416RLIP76, and988 Structure 18, 985–995, August 11, 2010 ª2010 Elsevier Ltd All riGln-417RLIP76. Asn-81RalB and Tyr-82RalB at the C-terminal end
of switch 2 contact residues in both a helices of RLIP76, whereas
residues just C-terminal to switch 2, Arg-84RalB and Ser-85RalB,
interact almost exclusively with a2RLIP76 (Figures 2B–2D).ghts reserved
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Figure 3. ComparisonofFreeRalB$GMPPNP
(PDBCode 2KE5) and RLIP76 GBDwith Their
Structures in the Complex
(A) The RalB-RLIP76 complex with the contributing
free proteins overlaid. RalB is shown in blue
(complex) and green (free), and RLIP76 GBD is
shown in lilac (complex) and yellow (free). The
regions of greatest divergence in RalB, the switch
regions and the interswitch hairpin, are labeled.
(B) The RLIP76 GBD alone, in the structures adop-
ted in the free and complex forms, in an orientation
that shows the small changes in the lengths and
orientations of the a helices. The structure of free
RLIP76 GBD is yellow and that in the complex is
lilac. The closest structure to the mean is shown
in each case.
Structure
Solution Structure of the RalB-RLIP76 ComplexComparison of Free and Bound Structures
A comparison of the structure of the RLIP76 GBD in its free and
RalB-bound form (Figure 3A) reveals that the overall topology of
the GBD does not change. There are however, minor changes in
the two a helices that comprise the GBD (Figure 3B). The helices
are slightly different lengths: 395–414 and 424–444 in the free
GBD, compared with 393–418 and 423–444 in the complex
(averaged over the ensemble of structures, using Procheck-
NMR) (Laskowski et al., 1993). The slight differences at the
extreme N and C termini of the GBD are unlikely to be significant,
because there are few restraints tying down these regions of the
structure. The N-terminal a-helix is, however, one turn longer at
its C-terminal end in the complex than in the free GBD, finishing
at Arg-414 in the free GBD and Gly-418 in the complex. The
differences in the end of this helix and in the interhelix loop are
the result of the interaction with RalB; there are unambiguous
intermolecular NOEs locking His-413 and Gln-417 against
switch 2 of RalB. The consequence of these interactions is that
the side-chains 413 and 417 must face the same way, and the
logical solution to this is to extend the a-helix. The shorter a helix
in the free GBD results in a somewhat longer interhelix loop,
which is less well-defined in the family of structures and thus
presumably more mobile. The overall inter-helical angle in the
GBD is approximately the same, around 155 to 160,
although some reorientation of the helices is evident (Figure 3).
This slight reorientation does not change the overall side-chain
packing between the helices.
Comparison of the RalB structure with that of the published
free RalB structure (Fenwick et al., 2009) shows that the overall
fold is, as expected, very similar. The changes are confined to
the two switch regions and the b-hairpin between the switches
(Figure 3A), which are the main points of contact with RLIP76.
As mentioned above, some resonances for residues within
switch I, including those for Thr-46, were missing in both the
free and the complex RalB$GMPPNP NMR spectra, presumablyStructure 18, 985–995, August 11, 2010because of conformational exchange.
It has been observed previously that
31P NMR spectra of small G proteins,
including Ha-Ras (Geyer et al., 1996), at
low temperatures, reveal that there are
two sets of NMR signals for each phos-
phate group in the GTP. These havebeen suggested to be due to the existence of two states
(known as state 1 and state 2) whose interconversion is slow
enough at low temperature to be visible by NMR. The first of
these states is unable to bind to effectors, whereas state 2 is
competent for effector binding. The addition of an excess
of the effector Raf led to a single set of peaks for Ha-Ras,
presumably as a result of the stabilization of state 2 (Geyer
et al., 1996). When similar experiments were performed on
RalB$GTP, we found that there were also two states apparent
at low temperatures, but that in contrast to the situation with
Ha-Ras, the addition of an excess of Sec5 only led to partial
stabilization of state 2 (Fenwick et al., 2009) and that state 1
was still visible. We have investigated the effect of binding of
RLIP76 GBD to RalB$GTP on the 31P NMR spectra. As expected
from previous work, the free RalB$GTP spectrum exhibited
a splitting of phosphate signals into state 1 (9.94 ppm) and
state 2 (10.93 ppm) when the temperature was lowered from
25C to 6C (compare Figure 4A and Figure 4B). When
RLIP76 was added in a 1.5-fold excess, we found that, as for
Sec5, the splitting of 31P resonances persisted at low tempera-
tures (Figure 4D). The a resonance is split into two discrete
components, and the b resonance has a distinct shoulder
at 15 ppm.
It has been proposed that the two states observed in Ha-Ras
are due to the effects of the Tyr-32 ring (equivalent to Tyr-43 in
RalB), which points toward the b-phosphate in the more active
state 2 and away from the b-phosphate in the less active
state 1. In the RalB-RLIP76 complex, Tyr-43 is not well defined,
although its side-chain points away from the nucleotide. The
dynamic nature of this side-chain in the complex is consistent
with the splitting in the 31P NMR spectrum even in the presence
of RLIP76. It is noteworthy that the splittings observed for the
a resonance are the most pronounced, even though it is the
b-phosphate that would be most affected by the orientation of
the Tyr-43 side-chain. This finding implies that the position ofª2010 Elsevier Ltd All rights reserved 989
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Figure 4. 31P NMR Spectra Recorded on RalB$GTP
(A) RalB$GTP recorded at 25C. The phosphorus resonances for the GTP
attached to RalB are labeled and were assigned as described elsewhere
(Fenwick et al., 2009). The resonances labeled ‘‘d’’ are likely to be due to small
amounts of contaminating GDP in the sample (Geyer et al., 1996).
(B) The same sample recorded at 6C. Each of the three phosphorus reso-
nances is split into two at low temperatures, and their positions are marked
by dotted lines. Note that the GDP peak that is close to the a resonance
contributes to the state 1 component of the a resonance at 9.94 ppm at
low temperatures. This has the effect of making the state 1 component larger
than the state 2 component (10.93 ppm), whereas previously the state 2
component was larger (Fenwick et al., 2009).
(C) The spectrum of RalB$GTP recorded in the presence of excess RLIP76
GBD at 25C.
(D) The same sample recorded at6C. The splitting is still visible for the a and
b resonances. Although the GDP peak is again contributing to the state 1
component of the a resonance, it cannot account for all of the intensity of
the state 1 peak, since the GDP peak at 9.5 ppm is of a lower intensity
than the peak at 1.0 ppm in this sample.
Structure
Solution Structure of the RalB-RLIP76 ComplexTyr-43 may not be the only factor that causes the splitting
observed for the phosphate groups in RalB$GTP.
It has been suggested that the preference for state 1 in M-Ras
results in rather low effector affinities (Ye et al., 2005). In the case
of RalB$GTP, the interaction with Sec5 and with RLIP76 are still
of a high affinity: 150 nM (Fenwick et al., 2009) and 184 nM (see
below), respectively, even though the 31P spectra show that both
states are present in solution in the presence of excess Sec5 or990 Structure 18, 985–995, August 11, 2010 ª2010 Elsevier Ltd All riRLIP76. This finding suggests that, at least for RalB$GTP, both
states are competent for binding to effectors.
Interactions Conserved in Evolution Are Important
for Affinity
The RLIP76 GBD, in common with most coiled-coil domains, is
held together mainly through hydrophobic interactions between
the two a helices. The residues involved in these interactions
tend to have aliphatic side-chains, such as leucine and isoleu-
cine. It is notable that this domain has just three aromatic resi-
dues (Phe-407, His-413, and Trp-430) and that all of them are
solvent-exposed in the free GBD structure. Furthermore, His-
413RLIP76 and Trp-430RLIP76 are involved in multiple interactions
with RalB in the complex, mainly with residues in switch 2. His-
413RLIP76 forms a hydrogen bondwith Tyr-82RalB as well as inter-
acting with Ala-48RalB, Ala-77RalB, and Ile-78RalB, although it is
not completely buried in the complex (Figures 2C and 2D). Trp-
430RLIP76, on the other hand, is completely buried when
RLIP76 forms a complex with RalB and is caged by the side-
chains of multiple residues in switch 2 and in b1RalB (Figure 2E).
The hydrophobic side-chains of Leu-67RalB and Ile-18RalB lie on
either side of the Trp-430RLIP76 ring, whereas the top and bottom
of the ring is capped by the hydrophobic portions of Lys-16RalB
and Tyr-82RalB.
Both His-413 and Trp-430 are completely conserved within
RLIP76 orthologs in a range of organisms from Caenorhabditis
elegans to humans (Figure 5A). The Ral proteins are also highly
conserved between these organisms and within the RLIP76-
interacting regions are 100% identical (Figure 5B). Overall, this
suggests that the interactions involving these side-chains will
also be conserved.
We set out to test the importance of some of these interactions
bymaking a series of pointmutations inRalBwhere the residue of
interest was changed to alanine. All mutants were constructed in
a background of Q72L RalB. This mutation decreases the GTP
hydrolysis rate, allowing the GTP-bound form to be stable during
the course of the experiment. Using scintillation proximity assays
(SPA) with Q72L RalB$GTP and C-terminally His-tagged RLIP76
GBD, a Kd of 184 nM was obtained (Figure 6). Some of the resi-
dues that contact His-413 can bemutated with relatively modest
effects on the affinity of the interaction (e.g., I78A and A77R bind
with a Kd of 724nM and 585 nM, respectively, equivalent to only
a 4.0-fold and 3.2-fold decrease in affinity, respectively). Muta-
tion of other residues, however, has a more dramatic effect.
Tyr-82RalB, which forms a hydrogen bond with His-413RLIP76, is
also involved in hydrophobic contacts with Trp-430 RLIP76
(Figures 2C–2E). Mutation of Tyr-82RalB to Ala reduced the
binding to RLIP76 significantly, increasing the Kd to >1 mM,
thus increasingDGbyat least 0.9 kcal/mol. This interaction there-
fore contributes significantly to thebinding energyof the complex
(DG Q72L RalB-RLIP76 is 9 kcal/mol). Leu-67RalB also makes
hydrophobic interactions with Trp-430 (Figure 2E) and the L67A
mutant also increases the Kd to >1 mM. Overall, these mutational
data suggest that contacts involving the Trp-430RLIP76 side-chain
are important for the affinity of the interaction.
Discrimination Between Ral and Ras Effectors
The structure presented here is the first example of a complex
involving RalB, one of the two human variants of Ral.ghts reserved
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Figure 5. Sequence Alignments
(A) Alignment of RLIP76 GBD from different organisms. The
positions of a helices in the structure are shown as gray cylin-
ders on the top of the alignment. Residues that are conserved
in all sequences are colored white on a black background.
Residues whose properties are conserved are boxed. The
stars above the sequences mark the position of residues
that interact with RalB. Hs, Homo sapiens; Mm, Mus muscu-
lus; Gg, Gallus gallus; Tn,Tetraodon nigroviridis; Xl, Xenopus
laevis; Dr,Danio rerio; Is, Ixodes scapularis; Bf,Branchiostoma
floridae; Dm, Drosophila melanogaster; Aa, Aedes aegypti;
Am, Apis mellifera; Ce – Caenorhabditis elegans.
(B) Alignment of the N-terminal regions of RalA, RalB, and
Ha-Ras. The positions of a helices in the Ral B structure are
shown as gray cylinders and the b strands as gray arrows,
on the top of the alignment. Residues that are conserved
between all three sequences are boxed. The stars above the
sequences indicate the residues that interact with RLIP76
GBD.
Structure
Solution Structure of the RalB-RLIP76 ComplexComparison of the structures of RalA$GMPPNP (Nicely et al.,
2004) and RalB$GMPPNP (Fenwick et al., 2009) shows that
they are broadly similar. The residues that interact with RLIP76
are identical in RalA and RalB (Figure 5B), and this conservation
is reflected in a comparable in vitro affinity of both G proteins for
this effector (data not shown and Bauer et al., 1999). We
observed similar parity in vitro with RalA and RalB for the effector
Sec5 (Fenwick et al., 2009). Most of the Ral residues that interact0 0.2 0.4 0.6 0.8 1 1.2 1.4 1.6 1.8 2
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Structure 18, 985–995, Auguswith RLIP76 are also identical in Ha-Ras, and the
switch regions in particular are well conserved
between the G proteins (Figure 5B). Ha-Ras does
not, however, bind to RLIP76, and Ral does not
bind to Ras effector proteins (Jullien-Flores et al.,
1995; Cantor et al., 1995; Park and Weinberg,
1995). A binding analysis of RalA and Ha-Ras
combined with mutagenesis of both proteins pin-
pointed two residues in switch 1, Lys-47 and
Ala-48 (Ral numbering), as important for discrimi-
nation between Ras and Ral effectors (Bauer
et al., 1999). These residues are replaced by Ile-36
and Glu-37, respectively, in Ras and represent
the most drastic changes in sequence within the
switches. Essentially, this region is positively
charged in Ral proteins and negatively charged inRas. The RalB K47I mutant showed little change in its ability
to bind to RLIP76, A48E binding was compromised, and the
double K47I/A48E mutant showed no binding at all to RLIP76
by yeast two-hybrid and GST-pull-down assays (Bauer
et al., 1999). Our SPA data are in broad agreement with these
results, with the A48G mutant showing a five-fold decrease in
affinity and the K47A mutant having little effect (Figure 6). Ala-
48RalB is in the interface and packs against Leu-409RLIP76 andFigure 6. Measurement of the Affinities of Q72L RalB
and Selected Mutants for the RLIP76 GBD
The indicated concentration of [3H] GTP-labeled RalB were
incubated with 80 nM RLIP76 GBD-His in SPAs. The SPA
signal was corrected by subtraction of a blank from which
RLIP76 GBD-His was omitted. The effect of RalB on this
corrected SPA counts/minute signal was fitted to a binding
isotherm to give an apparent Kd value and the signal at satu-
rating concentrations of RalB. The data are expressed as
a percentage of this maximum signal. The calculated Kd
values were: RalB Q72L, 183.9 ± 19.9nM; RalB Q72L K47A,
339.5 ± 34.7nM; RalB Q72L A48G, 945.5 ± 60.7; RalB Q72L
L67A, >1 mM; RalB Q72L A77R, 585.0 ± 50.2 nM; RalB Q72L
I78A, 724.2 ± 55.1 nM; RalB Q72L Y82A, >1 mM.
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Figure 7. Comparison of Structures of Ral-Effector Complexes
Shows That They Bind to Overlapping Interfaces of the G Protein
(A) RalB-RLIP76: RLIP76 uses a coiled-coil and binds to both switch 1 and
switch 2. RalB is blue and RLIP76 is lilac
(B) RalA-Exo84: Exo84 uses a PH domain and binds to both switch 1 and
switch 2. RalA is purple and Exo84 is orange.
(C) RalA-Sec5: Sec5 uses an immunoglobulin-like domain and binds exclu-
sively to switch 1 and the interswitch region. RalA is blue and Sec5 is red.
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Figure 8. Displacement of [3H]GTP$RalB from GST-Sec5 by RLIP76
Increasing concentrations of RLIP76 GBD were titrated into fixed concentra-
tions of [3H]GTP$RalB (20 nM) and GST-Sec5 GBD (20 nM) in competition
SPAs. The fit of the inhibition of the [3H]GTP$RalB/GST-Sec5 GBD interaction
is shown and yields a Kd of 199.4 ± 33.3 nM. This is the same as the Kd
measured by direct binding (Figure 6).
Structure
Solution Structure of the RalB-RLIP76 ComplexHis-413RLIP76 (Figures 2A and 2D); its replacement in Ras with
the negatively charged Glu would cause a rearrangement of
this packing and the loss of hydrophobic interactions. Lys-
47RalB does not interact directly with RLIP76; it points away
from the interface toward Glu-44RalB, which could pin Lys-
47RalB away from RLIP76 by forming a salt bridge. Lys-47RalB
replacement with an Ile residue would remove any potential
interaction with Glu-44RalB and allow rearrangement of this
loop in RalB in the double K47I/A48E mutant. The importance
of these residues to the affinity for RLIP76 is underlined by the
observation that the Ras double mutant I36K/E37A (i.e., to the
equivalent residues) is able to bind RLIP76 (Bauer et al., 1999).
Lys-47 is also important in the interaction between RalA and
the exocyst component Exo84 and is proposed to be a specificity
determinant for binding to this effector (Jin et al., 2005).
Comparison with RalA-Exocyst Component Complexes
RalA structures have been solved in complex with two different
components of the exocyst complex, Sec5 and Exo84.
A comparison of the three Ral complex structures reveals that
the effectors themselves are all strikingly different (Figure 7).
Sec5 GBD has an all b sheet, Ig-like fold, which forms an
intermolecular antiparallel b sheet with b2RalA (Figure 7C) inter-
acting exclusively with residues in and around switch 1 and992 Structure 18, 985–995, August 11, 2010 ª2010 Elsevier Ltd All riburying1000 A˚2 in the interface (Fukai et al., 2003). In contrast,
the Exo84 GBD is a PH domain (Figure 7B) that interacts
with both switch 1 and switch 2 of RalA (Jin et al., 2005).
Exo84 does not form an intermolecular b sheet with RalA and
buries 1700 A˚2 when it binds. The RLIP76 GBD-RalB
interaction also interacts with both switch 1 and switch 2 and
buries 1700 A˚2. In this way, it would appear to be more similar
to the Exo84 interaction. The Exo84 PH domain contains a single
a helix, which, although it makes some contacts with RalA, is not
the sole determinant in binding, because Exo84 also utilizes
a b strand in the binding interface. The fifth b strand of Exo84
interacts with b2RalA in a manner that resembles an intermolec-
ular parallel b sheet, although it is only held together by three
hydrogen bonds, between Ala-48/Ser-50RalA and Asn-231/Lys-
233Exo84 (Jin et al., 2005). The long a helix at the C terminus of
the PH domain is in approximately the same orientation as the
N-terminal a helix of the RLIP76 GBD (Figures 7A and 7B).
The two helices are however in slightly different positions, and
this is reflected in the interactions that they make: the Exo84
PH domain helix contacts residues further toward the N terminus
of Ral compared to those contacted by the RLIP76 GBD.
The binding sites for Exo84 and Sec5 were considered to be
partially overlapping because three residues in RalA, Ala-58,
Ser-50, and Arg-52 are shared in both binding interfaces.
These three residues are also in the binding interface with
RLIP76, and it is not surprising therefore that the Sec5 GBD
and RLIP76 GBD bind competitively (Figure 8). In addition to
these three interactions, the RLIP76 interface shares several
residues with the Exo84 interface—Lys-16, Asp-65, Ile-78,
Asn-81, and Tyr-82—and it is thus likely that the binding of these
two effectors will also be mutually exclusive.
Functional Consequences of the RLIP76-Ral Interaction
RLIP76 has several domains apart from the GBD, which
have been ascribed different functions. The best-characterized
sequence is the GAP domain, which is just N-terminal to the
GBD in the RLIP76 sequence. RLIP76 appears to behave asghts reserved
Structure
Solution Structure of the RalB-RLIP76 Complexa GAP toward both Cdc42 and Rac1, albeit with low activity
(Cantor et al., 1995; Jullien-Flores et al., 1995; Park and Wein-
berg, 1995), but its activity toward other Rho family proteins
has not been systematically investigated. Because the GAP
domain and the GBD are juxtaposed, it was an attractive possi-
bility that Ral binding would modulate the GAP activity in vivo,
but it seems that Ral has little effect on RLIP76 RhoGAP activity
in vitro (Park and Weinberg, 1995).
It has however recently been shown that phosphorylation of
RalA Ser194 by Aurora-A leads to its translocation from the
plasma membrane to endosomes and increased interaction
with RLIP76. This localizes RLIP76 to the same internal
compartments and results in a concomitant loss of filopodia
and lamellipodia, presumably because Cdc42 and Rac1 activity
is decreased (Lim et al., 2010). These results have two possible
explanations: either localizing RLIP76 to the correct compart-
ment brings it into contact with its substrates Rac1/Cdc42, or
RalA does have a direct effect on modulating the GAP activity
of RLIP76. RalA$GTP phosphorylated at Ser194 coimmunopre-
cipitates RLIP76 better than does GTP-loaded RalA that is not
phosphorylated, suggesting that the RalA C terminus may be
involved in the RLIP76 interaction in vivo. However analytical
gel filtration analyses we performed on full-length and C-termi-
nally truncated RalB show that both readily form complexes
with RLIP76 (data not shown), implying that the C terminus of
RalB does not affect the interaction with RLIP76, at least
in vitro. Furthermore, Ser194 is not conserved in RalB, suggest-
ing that the two Ral isoformsmay differ in the nature of their inter-
action with RLIP76 in this region. The C-terminal polybasic
region of Rac1 has been shown to contribute to interaction
with the coiled-coil HR1b domain of the effector PRK1 (Modha
et al., 2008) so there is a precedent for the C terminus of small
G proteins to be involved in effector binding.
RLIP76 has also been shown to bind to ATP, which is
necessary for its function as a xenobiotic transporter (Awasthi
et al., 2001). One ATP motif is within the RLIP76 GBD
(418GGIKDLSK425) and encompasses the loop between the two
helices. It is likely, however, that more than the simple coiled-
coil that comprises the minimal GBD would be required to form
an ATP-binding site. It is therefore not surprising that we have
been unable to detect ATP binding to the RLIP76 GBD either
alone or in the presence of RalB (data not shown).
Given the importance of Ral and RLIP76 in diseases such as
cancer, it is crucial to determine the precise effects of Ral binding
on these two major functions of RLIP76. This knowledge will
depend on further structural and biochemical investigations
on the remainder of the RLIP76 protein. This first insight into
the Ral/RLIP76 interaction at a molecular level is a starting point
to elucidate the functions of these two proteins in disease
progression.
EXPERIMENTAL PROCEDURES
Protein Expression and Purification
Human RalB residues 1–185, containing the activating mutation Q72L (hence-
forth referred to as RalB), were cloned into pET16b (Novagen) and expressed
in Escherichia coli BL21(DE3) (Invitrogen). Unlabeled and uniformly labeled
RalB proteins incorporating 15N or 15N and 13C were expressed and purified
as described elsewhere (Prasannan et al., 2007). The protein was concen-
trated to 0.6 mM, and the bound nucleotide was exchanged for GTP or itsStructure 18, 98nonhydrolyzable analog GMPPNP (Sigma), as described elsewhere (Fenwick
et al., 2009; Thompson et al., 1998). The presence of the bound nucleotide
was confirmed by HPLC analysis.
The GBD of human RLIP76 (393–446) was amplified by PCR and cloned into
pGEX-4T3 (Invitrogen) using BamHI and XhoI restriction sites that had been
incorporated into the PCR primers. The C411S mutation was introduced
into the RLIP76 GBD expression construct by site-directed mutagenesis using
the QuikChange Multi Site Directed Mutagenesis Kit (Stratagene) following
the manufacturer’s instructions. The construct was expressed in E. coli
BL21 (Invitrogen). The unlabeled and uniformly labeled RLIP76 GBD proteins
were produced as described elsewhere (Fenwick et al., 2008b).
The GBD of human RLIP76 (393–446) was also cloned into a modified
version of pGEX-His-2 (Strugnell et al., 1997). A thrombin cleavage site was en-
gineered into pGEX-His-2, 50 to the BamHI cloning site. RLIP76 (393–446) was
amplified by PCR and cloned into modified pGEX-His-2 using BamHI and
XhoI restriction sites that had been incorporated into the PCR primers. The
resulting construct expressed GST-RLIP76 GBD with a C-terminal His tag.
The C411S mutation was introduced as described above. The construct
was expressed in E. coli BL21 (Invitrogen). A 50 mL overnight culture of the
construct was diluted into 500 mL of 2TY, was grown to an A600 of 0.8,
was induced with 0.1 mM IPTG, and was grown for a further 5 hr. Cells were
lysed and the fusion protein purified using glutathione agarose (Sigma-Aldrich)
following the manufacturer’s instructions. The fusion protein was cleaved with
thrombin to remove theGST tag and further purified by gel filtration (S30 16/60,
GE Healthcare). This protein was then used directly in SPAs.
Mutations were introduced, as specified, into the coding region of RalB
using the QuikChange Multi Site Directed Mutagenesis Kit (Stratagene)
following the manufacturer’s instructions. The sequences of the coding
regions of all mutants were verified using an automated DNA sequencer
(Applied Biosystems) by the DNA Sequencing Facility of the Department of
Biochemistry at the University of Cambridge. Proteins were expressed and
purified as described elsewhere (Prasannan et al., 2007).
NMR Spectroscopy
The sample used to determine the structure of the free RLIP76 GBD C411S
contained 0.8 mM 15N-labeled protein in 50 mM sodium phosphate (pH 6.3),
100 mM NaCl, 1 mM MgCl2, 10 mM 2-mercaptoethanol, 0.05% NaN3 and
10% (v/v) D2O. Experiments on free RLIP76 were recorded on a Bruker
DRX500 at 25C and included 2D 15N HSQC, 3D 15N-separated NOESY (mix-
ing time 130 ms), 3D 15N-separated TOCSY, 2D NOESY (mixing time 130 ms),
2D TOCSY, and 2D DQF-COSY.
Mixed samples of the RalB-RLIP76 GBD C411S complex were prepared
containing one labeled and one unlabeled protein. The samples contained
a 10% excess of the unlabeled component, which was sufficient to ensure
saturation of the labeled component. NMR samples contained 50 mM sodium
phosphate (pH 7.6 or pH 6.8), 100 mM NaCl, 1 mM MgCl2, 0.05% NaN3 and
10% (v/v) D2O. Two pH conditions were used to optimize the NMR spectra
for the labeled component in the complex. The affinities were measured at
the different conditions and they were not affected by the pH change (data
not shown). All experiments were recorded on Bruker DRX spectrometers
at 25C. The following experiments were recorded on the labeled RalB
(reviewed in Cavanagh et al., 2007): 2D 15N HSQC, 3D HNCA, HNCO, HN
(CO)CA, HNCACB, CBCA(CO)NH, (H)C(CCO)NH, 2D 13C HSQC, 2D methyl-
selective CT HSQC, HC(C)H TOCSY, H(C)CMeHMe TOCSY HMeCMeCgba, and
(H)CCMeHMe TOCSY (D.N., unpublished data). The experiments recorded on
the labeled RLIP76 GBD C411S were 2D 15N HSQC, 3D HNCA, HNCO, HN
(CO)CA, HNCACB, 13C HSQC, 3D (H)C(CCO)NH, HBHA(CBCACO)NH,
and HC(C)H TOCSY. For NOE restraint generation, 15N-separated NOESY,
13C-separated NOESY, and 13C-filtered, 13C-separated NOESY experiments
were recorded on each sample on a Bruker DRX800. The samples for 31P
NMR experiments contained 0.3 mM RalB$GTP in 10 mM Tris-HCl (pH 7.4),
200 mM NaCl, 1 mM MgCl2, 0.05% NaN3, and 10% (v/v) D2O or 0.2 mM
RalB$GTP and 0.3 mM RLIP-76 GBD in the same buffer. The experiments
were recorded on a Bruker DRX500 at 25C or 6C.
Assignment and Structure Calculation
The assignment of spectra and generation of NOE distance restraints was
achieved using the CCPN Analysis program (Vranken et al., 2005), and the5–995, August 11, 2010 ª2010 Elsevier Ltd All rights reserved 993
Structure
Solution Structure of the RalB-RLIP76 Complexassignments are reported elsewhere (Fenwick et al., 2008a, 2008b). Dihedral
restraints were generated from the chemical shifts using TALOS (Cornilescu
et al., 1999), and the structure calculations were run using CNS 1.2 with the
Aria 1.2 protocols (Brunger et al., 1998; Linge et al., 2001). Hydrogen bonds
used in the structure calculationswere inferred for the RLIP76GBD from amide
exchange rates (Hwang et al., 1998). Restraints were added tomodel amagne-
sium ion with octahedral geometry, coordinated to twomolecules of water, the
b and g phosphates and residues Ser-28RalB and Thr-46 RalB. The structure
calculations of the unbound RLIP76 GBD started from a structure of an
extended chain, whereas the calculations of the complex started from the
coordinates of free RalB (Fenwick et al., 2009) and the RLIP76 GBD structures,
with randomized orientations with respect to one another. One hundred struc-
tures were calculated in the final iteration, and the 50 lowest energy structures
were selected for further analysis.Scintillation Proximity Assays
Direct binding SPAs
Affinities of RalB proteins for RLIP76 GBD-His were measured using scintilla-
tion proximity assays (SPAs), in which His-tagged fusion protein was attached
to a fluoromicrosphere via an anti-His antibody (Sigma) in the presence of
Q72L RalB$[3H]GTP or mutant variants. Binding of the G protein to the
RLIP76 GBD-His brings the labeled nucleotide close enough to the scintillant
to obtain a signal. Apparent Kd values for Q72L RalB$[
3H]GTP and proteins
incorporating further mutations were measured as described elsewhere
(Thompson et al., 1998) by varying the concentration of RalB$[3H]GTP at
a constant concentration of RLIP76 GBD-His. These assays were performed
with 80 nM RLIP76 GBD-His. Using this method, the upper and lower limits
of the Kd that can accurately be measured are 1000 and 1 nM, respectively.
For each affinity determination, data points were obtained for at least 10
different RalB concentrations. Binding curves were fitted using the appropriate
binding isotherms to obtain Kd values and their standard errors (Thompson
et al., 1998; Graham et al., 1999).
Competition SPAs
For competition assays, free RLIP76 GBD was titrated into a mixture of 20 nM
[3H]GTP$RalB and 20 nMGST-Sec5 RBD immobilized on fluoromicrospheres,
as described above. The added RLIP76 GBD competes with the GST-Sec5
GBD/[3H]GTP$RalB interaction, abolishing the scintillation signal. The highest
sample concentrations of competitor used were 2 mM. In each case, a blank
was performed in the absence of GST-Sec5 GBD. For the RalB-RLIP76
GBD affinity determination, data points were obtained for at least 10 different
competitor concentrations. TheKd value and its standard errors were obtained
by fitting the dose-response curve to binding isotherms that describe compe-
tition between two proteins binding to one site on another protein and account
for mutual depletion of the interacting components. The value of Kd for the
GST-Sec5/RalB interaction was also required and this was obtained from
direct binding SPAs (Fenwick et al., 2009). The equations used were adapted
for SPA from the previously published derivations (Wang, 1995) and have been
fully described elsewhere (Elliot-Smith et al., 2007).ACCESSION NUMBERS
NMR assignments have been deposited in BioMagResBank accession
numbers 15524 (RLIP76) and 15525 (RLIP76-RalB complex). The coordinates
have been deposited in the RCSB protein data bank, accession numbers
2KWH (RLIP76) and 2KWI (RLIP76-RalB complex).ACKNOWLEDGMENTS
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